Skip to content
Screener

LifeMD, Inc. LFMD Q4 2025 Annual earnings

Reported March 9, 2026 · After market close

Revenue$46.9MBeat by $1.0M
EPS-$0.04Miss by $0.03
Revenue estimate$45.8M
EPS estimate-$0.01

Next report

Nov 11, 2026 (in 2 months)
Revenue estimate$48.9M
EPS estimate-$0.14

Financials

Q4 2025

Income statement

See full
Revenue$7.1M+29.0%
Gross profit$2.8M—
Operating income-$6.2M-4.3%
Net income$20.0M+504%
EPS (diluted)$0.43+407%

Balance sheet

See full
Cash & equivalents$36.8M+12.7%
Total debt$6.3M-73.2%
Total equity$23.2M+355%
Total assets$70.4M-7.5%

Cash flow

See full
CapEx$155.5K-21.5%

Valuation & ratios

Valuation

as of 12/31/25
See full
Market cap$164.14M-23.4%
Enterprise value$133.68M-34.9%
P/E11.4×—
P/S0.9×-0.5×

Profitability

See full
Gross margin85%-1.9pp
Operating margin-5.4%-2.1pp
Net margin7.9%+4.8pp

Returns & leverage

See full
Debt / equity0.3×—
Current ratio1.2×+0.5×

Segments

By segment

See full
Telehealth$46.9M+3.8%
Telehealth Subscription Revenue$26.8M+19.4%

FAQ

When did LifeMD, Inc. report Q4 2025 earnings?
LifeMD, Inc. (LFMD) reported Q4 2025 earnings on March 9, 2026 after market close.
What were LifeMD, Inc.'s Q4 2025 revenue and EPS?
LifeMD, Inc. reported revenue of $46.9M and eps of $-0.04 for Q4 2025.
Did LifeMD, Inc. beat estimates in Q4 2025?
Revenue beat the consensus estimate of $45.8M by $1.0M. EPS missed the consensus estimate of $-0.01 by $0.03.
How did LifeMD, Inc.'s Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 27.1% from $64.3M a year earlier and eps declined 100.0% from $-0.02.
Where can I find LifeMD, Inc.'s Q4 2025 SEC filings?
You can read the 8-K earnings release (0001493152-26-009380) and the 10-K periodic report (0001493152-26-009549) directly on SEC EDGAR. The filing index links above go to sec.gov.